Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Apple
AAPL
|
+$9.29B |
| 2 |
NVIDIA
NVDA
|
+$1.77B |
| 3 |
Broadcom
AVGO
|
+$1.59B |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.52B |
| 5 |
T-Mobile US
TMUS
|
+$1.48B |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$3.16B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.92B |
| 3 |
Amazon
AMZN
|
+$2.22B |
| 4 |
Microsoft
MSFT
|
+$2.14B |
| 5 |
Merck
MRK
|
+$1.72B |
Sector Composition
| 1 | Technology | 24.16% |
| 2 | Healthcare | 19.43% |
| 3 | Financials | 13.51% |
| 4 | Consumer Discretionary | 9.13% |
| 5 | Industrials | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Primerica
PRI
$8.9B
| $1.05M | ﹤0.01% |
4,450
-14,265
| -76% | -$3.37M |
|
1552
Acadia Pharmaceuticals
ACAD
$4.28B
| $1.05M | ﹤0.01% |
64,774
+6,507
| +11% | +$106K |
|
|
INZY
1553
DELISTED
Inozyme Pharma
INZY
| $1.04M | ﹤0.01% |
232,980
-11,220
| -5% | -$50K |
|
1554
Baxter International
BAX
$12.4B
| $1.04M | ﹤0.01% |
31,010
+6,339
| +26% | +$212K |
|
1555
Altimmune
ALT
$327M
| $1.03M | ﹤0.01% |
154,679
-2,235
| -1% | -$14.9K |
|
1556
Nkarta
NKTX
$151M
| $1.02M | ﹤0.01% |
173,306
+43,932
| +34% | +$260K |
|
1557
American Financial Group
AFG
$11.5B
| $1.02M | ﹤0.01% |
8,323
+328
| +4% | +$40.4K |
|
1558
Anika Therapeutics
ANIK
$129M
| $1.02M | ﹤0.01% |
40,282
+2,981
| +8% | +$75.5K |
|
1559
Old Republic International
ORI
$10B
| $1.01M | ﹤0.01% |
32,734
-40,894
| -56% | -$1.26M |
|
1560
Zebra Technologies
ZBRA
$16B
| $1.01M | ﹤0.01% |
3,274
+332
| +11% | +$103K |
|
1561
Allison Transmission
ALSN
$7.52B
| $1.01M | ﹤0.01% |
+13,323
| New | +$1.01M |
|
1562
Beam Therapeutics
BEAM
$2.02B
| $1.01M | ﹤0.01% |
43,108
+10,155
| +31% | +$238K |
|
1563
Aecom
ACM
$16.8B
| $1.01M | ﹤0.01% |
11,453
+617
| +6% | +$54.4K |
|
1564
SPDR S&P International Small Cap ETF
GWX
$781M
| $1M | ﹤0.01% |
31,653
+12,774
| +68% | +$405K |
|
1565
Arcellx
ACLX
$3.94B
| $1M | ﹤0.01% |
18,200
+2,503
| +16% | +$138K |
|
1566
Gen Digital
GEN
$18.4B
| $997K | ﹤0.01% |
39,912
+923
| +2% | +$23.1K |
|
1567
ARS Pharmaceuticals
SPRY
$1.06B
| $995K | ﹤0.01% |
116,883
+3,678
| +3% | +$31.3K |
|
1568
Nuvation Bio
NUVB
$1.19B
| $994K | ﹤0.01% |
+340,331
| New | +$994K |
|
1569
KalVista Pharmaceuticals
KALV
$796M
| $990K | ﹤0.01% |
84,023
+4,658
| +6% | +$54.9K |
|
1570
HilleVax
HLVX
$105M
| $984K | ﹤0.01% |
68,052
+6,129
| +10% | +$88.6K |
|
1571
Paycom
PAYC
$12.6B
| $983K | ﹤0.01% |
6,870
+3,308
| +93% | +$473K |
|
1572
Immunovant
IMVT
$2.85B
| $975K | ﹤0.01% |
36,929
-370,725
| -91% | -$9.79M |
|
1573
WESCO International
WCC
$10.6B
| $967K | ﹤0.01% |
6,098
-421
| -6% | -$66.7K |
|
1574
J.M. Smucker
SJM
$11.9B
| $965K | ﹤0.01% |
8,849
-348
| -4% | -$37.9K |
|
1575
Xeris Biopharma Holdings
XERS
$1.25B
| $950K | ﹤0.01% |
422,109
+25,164
| +6% | +$56.6K |
|